<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>viral clearance &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/viral-clearance/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 24 Oct 2026 10:26:53 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>viral clearance &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Cervicovaginal Lipid Signatures Linked to HPV Clearance or Persistence in Pilot Study</title>
		<link>https://bioengineer.org/cervicovaginal-lipid-signatures-linked-to-hpv-clearance-or-persistence-in-pilot-study/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 24 Oct 2026 10:26:53 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[12-HETE]]></category>
		<category><![CDATA[14-HDHA]]></category>
		<category><![CDATA[Cervical cancer]]></category>
		<category><![CDATA[cervicovaginal microenvironment]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[LC-MS/MS]]></category>
		<category><![CDATA[lipid mediators]]></category>
		<category><![CDATA[Mucosal immunity]]></category>
		<category><![CDATA[oxylipins]]></category>
		<category><![CDATA[Pilot Study]]></category>
		<category><![CDATA[viral clearance]]></category>
		<category><![CDATA[viral persistence]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=451607</guid>

					<description><![CDATA[An exploratory pilot study found that women who later cleared high-risk HPV infections had higher cervicovaginal concentrations of the lipid mediators 12-HETE and 14-HDHA during infection, along with distinct mediator correlation patterns compared with women whose infection persisted.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">451607</post-id>	</item>
	</channel>
</rss>
